← Back to Research Radar
Academic Publication Academic Publication

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

1,444
Citations
September 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
clinical practice guidelines management metabolic dysfunction-associated
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
78%
🔥

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

No description provided.
crossref.org › academic paper
0%

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma

No description provided.
crossref.org › academic paper
0%

2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

No description provided.
crossref.org › academic paper
0%

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patien...
crossref.org › academic paper
0%

Multiple myeloma: 2024 update on diagnosis, risk‐stratification, and management

AbstractDisease overviewMultiple myeloma accounts for approximately 10% of hematologic malignancies.DiagnosisThe diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacyt...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)'?

This literature focuses on:

Are there open-source GitHub repositories related to EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)?

Yes, open-source projects like slowmist/openclaw-security-practice-guide (This guide is designed for OpenClaw itself (Agent-facing), not as a traditional human-only hardening checklist.) are actively building upon these concepts.

Which startups are commercializing the technology behind EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)?

Products like JusticeFlow - AI-Powered Legal Practice are bringing this to market. Their focus is: Legal Practice Management with AI-Powered Intelligence.

What other academic literature is closely related to 'EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)'?

Yes, highly correlated activity was mapped. An entry titled 'EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative